Conference Day Two
Thursday, May 8
7:55 am Pre-Conference Welcome
Hear From A Range of Industry Professional Across Biopharma On Becoming The Most Successful Strategic Business Partner
8:00-10:00 am Perfecting The Art of The Business Partner to Build Stronger & More Influential Relationships in Biopharma Companies
Synopsis
- Building Cross Functional Synergy & How to Have the Right People in The Room to Drive Commercial Success
- Delving Into the Role Of FP&A As an Equal Partner in Commercial Success and The Art of Financial Storytelling
9:00 am Registration & Light Breakfast for Main Conference
10:10 am Chair’s Opening Remarks
Mastering Adaptability to Create to The Most Relevant Forecasts to Combat the Rapidly Changing Demands of Life Sciences
10:20 am Discover: Exploring The Strategies to Meet the Demands of Regulatory changes in Life Sciences
Synopsis
- How to adapt planning to meet unpredictable issues in regulation quickly create financial plans
- How to adapt to the contextual changes as well as the financial changes and how this might affect forecasting
- Exploring market trends to monitor regulatory changes, competitive landscapes, and funding trends to inform financial models
10:40 am Discover: Delving Into the Demands on Analysis from The Wider Company and Becoming the Most Adaptable Whilst Still Producing Quality Planning
Synopsis
- How to create layers of analysis so that for each level of business partner can understand the information being relayed
- Building adaptive frameworks to accommodate fluctuating priorities from stakeholders across departments
- Exploring the alignment financial planning with scientific, operational, and strategic goals across departments so that adaptability is transparent
11:00 am Round Table – Can We Be More Adaptable to Financial Scenarios Changing And What Does That Look Like To The Widder Company?
11:20 am Develop: What More can we Learn About Being Adaptable so our Forecast Best Reflects the Demands of Life Sciences?
Synopsis
- The ability to stay adaptable is essential in the rapidly demanding space of life sciences with regulations, interest rates, clinical volatility and much more.
A Q&A session facilitated by the chair
11:40 am Action: What Can we do in Our FP&A to Become More Adaptable?
Synopsis
Output Focused Action Session Facilitated by the Chair
12:00 pm Morning Break & Networking
Understanding The ‘Cash’ Inflection Points and What Milestones to Meet, Creating A Successful Long Range Plan (LRP) That Aligns Scientific and Corporate Goals
12:30 pm Panel Discussion: Understanding The Trade-Off Between Lead Programs and Early-Stage Assets to Ensure Investment Is Carefully Placed for Corporate Goals
Synopsis
- How to balance the needs of different research teams so that project can continue as intended
- How to be transparent across the business in which investments will create the greatest ROI
- Assessing timelines of products and deciding at what stage to expand into new projects to ensure long term capital
12:50 pm Discover: Assessing The Cash Inflection Points Within Clinical Development and Creating A LRP For the Influx of Cash Needed at Which Stages in Development to Ensure Clinical Success
Synopsis
- How to assess at which points of clinical development will require excess funding to ensure long range success
- Integrating cross-department collaboration to identify cash demands and synchronize financial planning with clinical objectives
- Utilizing predictive models to anticipate resource requirements and adjust forecasts based on trial outcomes or recruitment challenges
1:10 pm Develop: What More Can We Learn From FP&A Leaders About Creating a Successful LRP?
Synopsis
- In the life science industry cash inflow can be increasingly challenging and changing, therefore LRPs must be watertight
A Q&A session facilitated by the chair
1:30 pm Action: How can we Best Ensure that our LRP is Clear and Secure?
Synopsis
Output Focused Action Session Facilitated by the Chair
1:50 pm Lunch & Networking
Managing CRO Contracts to Ensure Accuracy of Forecasting and Manage Risk to Avoid Financial Surprises and the Decisions that Need to be Made on Prioritisation of Investment
2:50 pm Discover: Navigating The Capital-Intensive Nature of Clinical Research for A Well Financially Supported Clinical Trial
Synopsis
- How to provide enough data quickly to prove efficacy and durability to ensure sponsorship and investment
- Managing aligning internal catalyst with funding timeline, so investment is well timed and meaningful to drive completion of trials
- How to ensure that CROs aren’t underbidding and how to make better informed decisions for accurate forecasting
3:10 pm Discover: Mitigating CRO Risk to Best Protect Your Clinical Trial Funding Throughout Contracts
Synopsis
- How to overcome hidden costs that may be associated with different setbacks in the trials such as patient recruitment
- Demystifying the common pitfall in CRO contracts that lead to poor cash outlook for clinal trials
- How to best mitigate uncertainty risk with CROs to manage risk and avoid unforeseen changes in cash flow
3:30 pm Develop: What More Can We Learn About Managing CRO Contracts To Ensure Accuracy In FP&A And Which Investments To Prioritize?
Synopsis
- Fluctuation in money can be extremely difficult, so it is essential that we best secure contracts with CROS to determine cash flow and ensure which investments need to be made at the correct time.
A Q&A session facilitated by the chair
3:50 pm Action: How can we Ensure CRO Contracts Are Well Planned And Watertight?
Synopsis
- How Can we Best Chose Which Investments to Make for the Biggest ROI?
Output Focused Action Session Facilitated by the Chair